Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2621-2023Class II

smith&nephew LEGION OXINUM POSTERIOR STABILIZED NONPOROUS FERMOAL COMPONENT, SIZE 5N, LEFT, NARROW, REF...

Smith & Nephew, Inc. / initiated 2023-08-31 / Open, Classified / root cause: labeling and UDI

Smith & Nephew Inc began a recall of smith&nephew LEGION OXINUM POSTERIOR STABILIZED NONPOROUS FERMOAL COMPONENT, SIZE 5N, LEFT, NARROW, REF 71421265; knee joint on . FDA classified it as Class II and gives the reason as "The firm conducting a recall due to a complaint received indicating that a package contained a LEGION NARROW PS OXIN SZ 4N LT implant instead of a LEGION NARROW PSvOXIN SZ 5N LT as described on the product label". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2621-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Smith & Nephew, Inc.
Product
smith&nephew LEGION OXINUM POSTERIOR STABILIZED NONPOROUS FERMOAL COMPONENT, SIZE 5N, LEFT, NARROW, REF 71421265; knee joint
Product code
JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Reason for recall
The firm conducting a recall due to a complaint received indicating that a package contained a LEGION NARROW PS OXIN SZ 4N LT implant instead of a LEGION NARROW PSvOXIN SZ 5N LT as described on the product label.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
Smith & Nephew issued an Urgent Medical Device3 Recall Notice to its consignees on 08/31/2023 via letter and email. The notice explained the problem and potential risk and requested the consignee quarantine the affected product. Distributors were directed to notify their customers. Firm is seeking return of the affected product.
Quantity in commerce
8 units
Distribution
OH, CT, TX, NC, CA, NE, NV
Product codes and lots
UDI/DI: 00885556234006, Lot Number: 23EM09878

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2621-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2621-2023Class IIOngoingVoluntary: Firm initiated